Literature DB >> 22986010

Prognostic factors during outpatient treatment for alcohol dependence: cohort study with 6 months of treatment follow-up.

P Aguiar1, D Neto, R Lambaz, J Chick, P Ferrinho.   

Abstract

AIMS: To identify prognostic factors to outpatient alcohol treatment on admission as well as during the treatment period.
METHODS: A cohort study of n = 209 alcoholic patients (DSM-IV) during 6 months of outpatient treatment. Eight medical doctors from two hospitals were involved. Co-responsible participation in treatment was a necessary condition. At admission, we documented socio demographic factors, use of other drugs and severity of alcohol consumption. During the 6 months, we observed medication for prevention of alcohol relapse [disulfiram (DIS), acamprosate], number of sessions with the doctor, number of phases of the consultation and medication for depression. Primary outcome variables were time to first heavy relapse and abstinence of heavy alcohol consumption. These were measured with Timeline Followback. Five or more alcohol units of 10 g in one relapse day were considered heavy relapse.
RESULTS: The patients were 84% males, with 41 years median age; the median alcohol consumption was 192 g per day with a median duration of 13 years of heavy consumption. The median education was 6 years with 61% of the patients from lower socio-economic levels. The Kaplan-Meier heavy relapse rate at 6 months was 23%. On admission to treatment, female gender, lower socio-economic levels, cocaine use, >20 years of consumption, gamma glutamyl transferase values above normal and five or more alcohol-related problems on the Alcohol-Related Problem Questionnaire predicted worse outcomes. Having a full-time job and shorter abstinence time before treatment (until 7 days) predicted better outcomes. During the 6 months, we found that DIS for <120 days was a prognostic factor of worse outcomes. DIS for at least 120 days, >50% of adherence to consultations and more than two phases on each consultation predicted better outcomes. The combined sensitivity and specificity for DIS for at least 120 days, >50% of adherence to consultations and more than two phases on consultation regarding abstinence from heavy relapse were respectively 100 and 71%.
CONCLUSIONS: During 6 months of outpatient treatment, longer adherence to DIS and consultations as well as more phases in a consultation involving necessarily a co-responsible predict a good outcome independently of the patient features at admission.

Entities:  

Mesh:

Year:  2012        PMID: 22986010     DOI: 10.1093/alcalc/ags097

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  7 in total

1.  Post-treatment drinking among HIV patients: Relationship to pre-treatment marijuana and cocaine use.

Authors:  Jennifer C Elliott; Efrat Aharonovich; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-03-21       Impact factor: 4.492

2.  Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram.

Authors:  Elise E DeVito; Theresa A Babuscio; Charla Nich; Samuel A Ball; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2014-10-20       Impact factor: 4.492

3.  Contingency management treatments are equally efficacious for both sexes in intensive outpatient settings.

Authors:  Carla J Rash; Nancy M Petry
Journal:  Exp Clin Psychopharmacol       Date:  2015-07-13       Impact factor: 3.157

4.  Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.

Authors:  Ryoko Susukida; Rosa M Crum; Elizabeth A Stuart; Cyrus Ebnesajjad; Ramin Mojtabai
Journal:  Addiction       Date:  2016-04-01       Impact factor: 6.526

5.  Frequency and Predictors of Alcohol-Related Outcomes Following Alcohol Residential Rehabilitation Programs: A 12-Month Follow-Up Study.

Authors:  Elena Fiabane; Lorenza Scotti; Antonella Zambon; Giovanni Vittadini; Ines Giorgi
Journal:  Int J Environ Res Public Health       Date:  2019-02-28       Impact factor: 3.390

6.  Classical blood biomarkers identify patients with higher risk for relapse 6 months after alcohol withdrawal treatment.

Authors:  Florian J Raabe; Elias Wagner; Eva Hoch; Gabriele Koller; Judith Weiser; Sarah Brechtel; David Popovic; Kristina Adorjan; Oliver Pogarell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-07-05       Impact factor: 5.270

7.  Treatment outcome, treatment retention, and their predictors among clients of five outpatient alcohol treatment centres in Switzerland.

Authors:  Severin Haug; Michael P Schaub
Journal:  BMC Public Health       Date:  2016-07-16       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.